Curia's Approach To Regulatory Compliance In Korea

Navigating foreign regulatory frameworks for active pharmaceutical ingredients requires strategic planning and rigorous quality controls. Entering key Asian bio-markets like South Korea demands strict compliance with the Ministry of Food and Drug Safety, which oversees everything from facility site registrations to active ingredient safety data. Securing market access hinges on compiling comprehensive technical documentation—such as impurity profiles, validation data, and analytical methods—under Korean Drug Master File submissions. Furthermore, international facilities must align their quality management systems with local Good Manufacturing Practices, which emphasize data integrity, robust change controls, and clear supplier qualification standards. Maintaining alignment between site records and regional filings mitigates compliance risks and protects supply continuity.

Review the full article to build a reliable compliance strategy for API supply and registration.